Medpace Holdings, Inc. (NASDAQ:MEDP) Shares Purchased by Polen Capital Management LLC

Polen Capital Management LLC lifted its holdings in shares of Medpace Holdings, Inc. (NASDAQ:MEDP - Free Report) by 8.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 16,223 shares of the company's stock after buying an additional 1,259 shares during the quarter. Polen Capital Management LLC owned approximately 0.05% of Medpace worth $5,390,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in MEDP. State Street Corp increased its position in shares of Medpace by 7.2% during the third quarter. State Street Corp now owns 752,957 shares of the company's stock worth $251,337,000 after purchasing an additional 50,312 shares in the last quarter. Geode Capital Management LLC increased its position in shares of Medpace by 7.6% during the third quarter. Geode Capital Management LLC now owns 628,054 shares of the company's stock worth $209,885,000 after purchasing an additional 44,371 shares in the last quarter. Wellington Management Group LLP increased its position in shares of Medpace by 36.0% during the third quarter. Wellington Management Group LLP now owns 415,255 shares of the company's stock worth $138,612,000 after purchasing an additional 109,886 shares in the last quarter. American Capital Management Inc. increased its position in shares of Medpace by 2.6% during the third quarter. American Capital Management Inc. now owns 380,646 shares of the company's stock worth $127,060,000 after purchasing an additional 9,592 shares in the last quarter. Finally, GW&K Investment Management LLC increased its position in shares of Medpace by 93.9% during the fourth quarter. GW&K Investment Management LLC now owns 275,460 shares of the company's stock worth $91,516,000 after purchasing an additional 133,379 shares in the last quarter. 77.98% of the stock is owned by institutional investors and hedge funds.

Remove Ads

Medpace Stock Performance

Shares of NASDAQ MEDP traded down $7.84 during mid-day trading on Thursday, reaching $319.63. 288,376 shares of the company's stock were exchanged, compared to its average volume of 287,575. The firm has a market capitalization of $9.74 billion, a price-to-earnings ratio of 25.31, a PEG ratio of 3.81 and a beta of 1.47. Medpace Holdings, Inc. has a 52-week low of $302.01 and a 52-week high of $459.77. The company's 50-day moving average is $338.95 and its 200-day moving average is $340.25.

Medpace (NASDAQ:MEDP - Get Free Report) last released its quarterly earnings results on Monday, February 10th. The company reported $3.67 earnings per share for the quarter, topping analysts' consensus estimates of $2.96 by $0.71. Medpace had a return on equity of 51.48% and a net margin of 19.17%. As a group, equities analysts predict that Medpace Holdings, Inc. will post 12.29 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Separately, Robert W. Baird upped their target price on Medpace from $354.00 to $362.00 and gave the company a "neutral" rating in a report on Monday, January 27th. Seven investment analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat, the stock has an average rating of "Hold" and an average price target of $381.44.

Medpace Profile

Medpace Holdings, Inc engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance.